title: Aurintricarboxylic acid prevents GLUR2 mRNA down-regulation and delayed neurodegeneration in hippocampal CA1 neurons of gerbil after global ischemia.
abstract: Aurintricarboxylic acid (ATA), an inhibitor of endonuclease activity and other protein-nucleic acid interactions, blocks apoptosis in several cell types and prevents delayed death of hippocampal pyramidal CA1 neurons induced by transient global ischemia. Global ischemia in rats and gerbils induces down-regulation of GluR2 mRNA and increased alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-induced Ca2+ influx in CA1 before neurodegeneration. This result and neuroprotection by antagonists of AMPA receptors suggests that formation of AMPA receptors lacking GluR2, and therefore Ca2+ permeable, leads to excessive Ca2+ influx in response to endogenous glutamate; the resulting delayed neuronal death in CA1 exhibits many characteristics of apoptosis. In this study, we examined the effects of ATA on expression of mRNAs encoding glutamate receptor subunits in gerbil hippocampus after global ischemia. Administration of ATA by injection into the right cerebral ventricle 1 h before (but not 6 h after) bilateral carotid occlusion prevented the ischemia-induced decrease in GluR2 mRNA expression and the delayed neurodegeneration. These findings suggest that ATA is neuroprotective in ischemia by blocking the transcriptional changes leading to down-regulation of GluR2, rather than by simply blocking endonucleases, which presumably act later after Ca2+ influx initiates apoptosis. Maintaining formation of Ca2+ impermeable, GluR2 containing AMPA receptors could prevent delayed death of CA1 neurons after transient global ischemia, and block of GluR2 down-regulation may provide a further strategy for neuroprotection.
authors.affiliation: Department of Neuroscience, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
authors.forename: E M
authors.initials: EM
authors.lastname: Aronica
authors.forename: J A
authors.initials: JA
authors.lastname: Gorter
authors.forename: S
authors.initials: S
authors.lastname: Grooms
authors.forename: J A
authors.initials: JA
authors.lastname: Kessler
authors.forename: M V
authors.initials: MV
authors.lastname: Bennett
authors.forename: R S
authors.initials: RS
authors.lastname: Zukin
authors.forename: D M
authors.initials: DM
authors.lastname: Rosenbaum
mesh_terms: D000818:Animals; D001312:Aurintricarboxylic Acid / Q000008:administration & dosage*; D002545:Brain Ischemia / Q000503:physiopathology* / Q000517:prevention & control*; D016923:Cell Death / Q000187:drug effects; D015536:Down-Regulation; D005849:Gerbillinae; D006624:Hippocampus / Q000098:blood supply / Q000473:pathology / Q000503:physiopathology*; D017966:Pyramidal Cells / Q000473:pathology / Q000503:physiopathology*; D012333:RNA, Messenger / Q000096:biosynthesis; D051381:Rats; D018091:Receptors, AMPA / Q000502:physiology*
chemical_list: D012333:RNA, Messenger; D018091:Receptors, AMPA; D001312:Aurintricarboxylic Acid; C104722:glutamate receptor ionotropic, AMPA 2